North America Postmenopausal Vaginal Atrophy Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2022

1 Market Overview

1.1 Postmenopausal Vaginal Atrophy Treatment Introduction

1.2 Market Analysis by Type

1.2.1 Creams

1.2.2 Tablets

1.2.3 Patches

1.2.4 Rings

1.3 Market Analysis by Applications

1.3.1 Topical Estrogen

1.3.2 Systemic Estrogen

1.3.3 Non-hormonal Therapy

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Profile

2.1.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Pfizer News

2.2 Allergan

2.2.1 Profile

2.2.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Allergan News

2.3 Shionogi

2.3.1 Profile

2.3.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Shionogi News

2.4 Novo Nordisk

2.4.1 Profile

2.4.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Novo Nordisk News

2.5 Teva Pharmaceutical

2.5.1 Profile

2.5.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Teva Pharmaceutical News

2.6 Bayer.

2.6.1 Profile

2.6.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Bayer. News

3 North America Postmenopausal Vaginal Atrophy Treatment Market Competition, by Manufacturer

3.1 North America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share

3.4.2 Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share

3.5 Market Competition Trend

4 North America Postmenopausal Vaginal Atrophy Treatment Market Analysis by Countries

4.1 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries

4.2 North America Postmenopausal Vaginal Atrophy Treatment Sales by Countries (2012-2017)

4.3 North America Postmenopausal Vaginal Atrophy Treatment Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Type

5.1 North America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)

5.1.2 North America Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)

5.2 Creams Sales Growth and Price

5.2.1 North America Creams Sales Growth (2012-2017)

5.2.2 North America Creams Price (2012-2017)

5.3 Tablets Sales Growth and Price

5.3.1 North America Tablets Sales Growth (2012-2017)

5.3.2 North America Tablets Price (2012-2017)

5.4 Patches Sales Growth and Price

5.4.1 North America Patches Sales Growth (2012-2017)

5.4.2 North America Patches Price (2012-2017)

5.5 Rings Sales Growth and Price

5.5.1 North America Rings Sales Growth (2012-2017)

5.5.2 North America Rings Price (2012-2017)

6 North America Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Application

6.1 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)

6.2 Topical Estrogen Sales Growth (2012-2017)

6.3 Systemic Estrogen Sales Growth (2012-2017)

6.4 Non-hormonal Therapy Sales Growth (2012-2017)

7 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type

7.3 United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)

7.4 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer

7.4.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer

7.5 United States Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)

8 Canada Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type

8.3 Canada Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)

8.4 Canada Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer

8.4.2 Canada Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer

8.5 Canada Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)

9 Mexico Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type

9.3 Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)

9.4 Mexico Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer

9.4.2 Mexico Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer

9.5 Mexico Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)

10 Postmenopausal Vaginal Atrophy Treatment Market Forecast (2017-2022)

10.1 North America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022)

10.2 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Countries (2017-2022)

10.2.1 United States Postmenopausal Vaginal Atrophy Treatment Forecast (2017-2022)

10.2.2 Canada Postmenopausal Vaginal Atrophy Treatment Forecast (2017-2022)

10.2.3 Mexico Postmenopausal Vaginal Atrophy Treatment Forecast (2017-2022)

10.3 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Type (2017-2022)

10.4 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Application (2017-2022)

11 Postmenopausal Vaginal Atrophy Treatment Manufacturing Cost Analysis

11.1 Postmenopausal Vaginal Atrophy Treatment Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data SourceList of Tables and Figures

Figure Postmenopausal Vaginal Atrophy Treatment Picture

Table Product Specifications of Postmenopausal Vaginal Atrophy Treatment

Figure North America Sales Market Share of Postmenopausal Vaginal Atrophy Treatment by Types in 2016

Table Types of Postmenopausal Vaginal Atrophy Treatment

Figure Creams Picture

Table Major Manufacturers of Creams

Figure Tablets Picture

Table Major Manufacturers of Tablets

Figure Patches Picture

Table Major Manufacturers of Patches

Figure Rings Picture

Table Major Manufacturers of Rings

Table North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016

Table Applications of Postmenopausal Vaginal Atrophy Treatment

Figure Topical Estrogen Picture

Figure Systemic Estrogen Picture

Figure Non-hormonal Therapy Picture

Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Postmenopausal Vaginal Atrophy Treatment Type and Applications

Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Postmenopausal Vaginal Atrophy Treatment Type and Applications

Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shionogi Basic Information, Manufacturing Base and Competitors

Table Shionogi Postmenopausal Vaginal Atrophy Treatment Type and Applications

Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Type and Applications

Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Type and Applications

Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer. Basic Information, Manufacturing Base and Competitors

Table Bayer. Postmenopausal Vaginal Atrophy Treatment Type and Applications

Table Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)

Figure North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016

Figure North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017

Table North America Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)

Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016

Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017

Table North America Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017)

Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016

Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017

Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016

Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017

Figure North America Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Countries (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries (2012-2017)

Figure North America 2012 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries

Figure North America 2016 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Countries

Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Revenue by Countries (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Countries (2012-2017)

Table North America 2012 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Countries

Table North America 2016 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Countries

Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales Share by Type (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Revenue Share by Type (2012-2017)

Figure North America Creams Sales Growth (2012-2017)

Figure North America Creams Price (2012-2017)

Figure North America Tablets Sales Growth (2012-2017)

Figure North America Tablets Price (2012-2017)

Figure North America Patches Sales Growth (2012-2017)

Figure North America Patches Price (2012-2017)

Figure North America Rings Sales Growth (2012-2017)

Figure North America Rings Price (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales Share by Application (2012-2017)

Figure North America Topical Estrogen Sales Growth (2012-2017)

Figure North America Systemic Estrogen Sales Growth (2012-2017)

Figure North America Non-hormonal Therapy Sales Growth (2012-2017)

Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)

Figure United States Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)

Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)

Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)

Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)

Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)

Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)

Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016

Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017

Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)

Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016

Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017

Table United States Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)

Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)

Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)

Table Canada Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)

Table Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)

Table Canada Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)

Table Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)

Table Canada Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)

Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016

Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017

Table Canada Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)

Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016

Figure Canada Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017

Table Canada Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)

Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)

Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)

Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)

Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)

Table Mexico Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017

Table Mexico Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2017

Table Mexico Postmenopausal Vaginal Atrophy Treatment Export and Import (2012-2017)

Figure North America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Countries (2017-2022)

Table North America Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Countries (2017-2022)

Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast (2017-2022)

Figure Canada Postmenopausal Vaginal Atrophy Treatment Sales Forecast (2017-2022)

Figure Mexico Postmenopausal Vaginal Atrophy Treatment Sales Forecast (2017-2022)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022)

Table North America Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Type (2017-2022)

Table North America Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022)

Table North America Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Postmenopausal Vaginal Atrophy Treatment

Figure Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment

Figure Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis

Table Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016

Table Major Buyers of Postmenopausal Vaginal Atrophy Treatment

Table Distributors/Traders/ Dealers List